日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T cell immunity in glioma and potential implications for immunotherapy: A systematic review

胶质瘤中T细胞免疫及其对免疫治疗的潜在意义:系统性综述

Luning, Rosa; French, Pim J; Vanbilloen, Wouter J F; Dobber, Lisa; Van Hijfte, Levi; Hoogendijk, Raoull; van den Bent, Martin J; Debets, Reno; Geurts, Marjolein

A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancer

用于三阴性乳腺癌新辅助化疗反应分层的多基因模型

van den Ende, Nadine S; Smid, Marcel; Martens, John W M; Debets, Reno; Jager, Agnes; van Deurzen, Carolien H M

Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma

多价阿特珠单抗-脂质体偶联物作为增强黑色素瘤PD-L1阻断的活性免疫治疗平台

Cheng, Ziyun; Amin, Mohamadreza; van Brakel, Mandy; Sacchetti, Andrea; Kim, Robbert Q; Seynhaeve, Ann L B; Debets, Reno; Ten Hagen, Timo L M

HYpofractionated, dose-redistributed RAdiotherapy (HYDRA) versus conventional radiotherapy for head and neck cancer: planned interim analysis and dosimetric comparison from the phase I HYDRA trial

HYDRA(低分割剂量重新分布放射疗法)与常规放射疗法治疗头颈癌:HYDRA I期试验的计划中期分析和剂量学比较

Gunsch, Pascal A; Kroesen, Michiel; Debets, Reno; Keereweer, Stijn; van Meerten, Esther; Zindler, Jaap; van Werkhoven, Erik; Hoogeman, Mischa; Verduijn, Gerda M; Nout, Remi A; Elbers, Joris B W

Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy

肿瘤相关巨噬细胞:尚未开发的分子靶点,可用于改善基于T细胞的免疫疗法

Coelho, Rui M L; Debets, Reno; Hammerl, Dora

Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives

帕博利珠单抗不同给药方案的生物等效性:现状与展望

Malmberg, Ruben; Agema, Bram C; Hofman, Maaike M; Oosterveld, Stefani; Bins, Sander; Dumoulin, Daphne W; Joosse, Arjen; Aerts, Joachim G J V; Debets, Reno; Koch, Birgit C P; van der Veldt, Astrid A M; van Leeuwen, Roelof W F; Mathijssen, Ron H J

CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based Chemotherapeutics.

周细胞分泌的 CXCL10 介导 TNFα 诱导的肿瘤血管渗漏,并增强纳米颗粒化疗药物的外渗

Seynhaeve Ann L B, Liu Hui, Priester Marjolein I, Valentijn Mike, van Holten-Neelen Conny, Brouwer Rutger W W, van Brakel Mandy, Dik Willem A, van IJcken Wilfred F J, Debets Reno, Stubbs Andrew P, Ten Hagen Timo L M

Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological Studies

超声抽吸法获取的胶质母细胞瘤组织保留了淋巴细胞表型和活性,支持其用于免疫学研究。

Stavrakaki, Eftychia; Belcaid, Zineb; Balvers, Rutger K; Vogelezang, Lisette B; van den Bossche, Wouter B L; Alderliesten, Demi; Lila, Karishma; van den Bosch, Thierry P P; van Dongen, Jacques J M; Debets, Reno; Teodosio, Cristina; Dirven, Clemens M F; Lamfers, Martine L M

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer

基于基因表达的T细胞-基质富集(TSE)评分可预测尿路上皮癌对免疫检查点抑制剂的反应

Rijnders, Maud; Nakauma-González, J Alberto; Robbrecht, Debbie G J; Gil-Jimenez, Alberto; Balcioglu, Hayri E; Oostvogels, Astrid A M; Aarts, Maureen J B; Boormans, Joost L; Hamberg, Paul; van der Heijden, Michiel S; Szabados, Bernadett E; van Leenders, Geert J L H; Mehra, Niven; Voortman, Jens; Westgeest, Hans M; de Wit, Ronald; van der Veldt, Astrid A M; Debets, Reno; Lolkema, Martijn P

T lymphocyte-derived IFN-γ facilitates breast cancer cells to pass the blood-brain barrier: An in vitro study corroborating translational data.

T 淋巴细胞衍生的 IFN-γ 促进乳腺癌细胞穿过血脑屏障:一项体外研究证实了转化数据

Pedrosa Rute M S M, Kros Johan M, Schrijver Benjamin, Berrevoets Cor, Marques Rute B, van Eijck Casper C H J, Debets Reno, Leenen PieterJ M, Dik Willem A, Mustafa DanaA M